President

Dr. Parsa Nejad, founder of CytoPrecision, brings more than 20 years of global experience in discovery, preclinical and clinical research to Cyto Precision. He began his career with Darou Pakhsh pharmaceutical company in Iran and went on to spend some years with R.J Reynolds Tobacco Company and TheratechnologiesPharmaceutical Company.  Dr. Parsa Nejad holds a Master in Medical Microbiology from Tehran University of Medical Science, Tehran, Iran and a Ph.D. in Molecular Genetics from McGill University, Montreal, Canada. He pursued his post-doctoral research in department of human genetics, and school of dietetics at McGill University and department of pharmacology at Wake Forest University, North Carolina, USA.